| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rain Oncology Inc. | VP of Finance & Admin | Stock Option (Right to Buy) | 65,325 | 15 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | 14 Mar 2024 | 0 | $0 | 3 | Chief Financial Officer | 15 Mar 2024, 16:22 |
| /report/000110465923023389-cabatuan-nelson-2023-02-15 | Rain Oncology Inc. | 15 Feb 2023 | 1 | $0 | 4 | VP of Finance & Admin | 17 Feb 2023, 17:23 |
| /report/000089924322004838-cabatuan-nelson-2022-01-07 | Rain Therapeutics Inc. | 07 Jan 2022 | 1 | $0 | 4 | VP of Finance and Administration | 04 Feb 2022, 15:45 |
| /report/000089924321019568-cabatuan-nelson-2021-05-12 | Rain Therapeutics Inc. | 12 May 2021 | 1 | $0 | 4 | Officer | 14 May 2021, 18:37 |